微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | -2.48% | -93.75% | -43.35% | 116/159 | 1.21% | 兴齐眼药 | 32.91% | 行业排名> |
| 2025-06-30 | -1.73% | -31.06% | -133.78% | 117/159 | 0.26% | 翰宇药业 | 18.95% | 行业排名> |
| 2025-03-31 | -0.74% | -236.36% | 87.33% | 121/159 | -0.37% | 翰宇药业 | 11.39% | 行业排名> |
| 2024-12-31 | -5.84% | -106.36% | -356.25% | 115/159 | -9.52% | 百利天恒 | 181.27% | 行业排名> |
| 2024-09-30 | -1.28% | 50.77% | 3.03% | 120/159 | 4.23% | 百利天恒 | 186.1% | 行业排名> |
| 2024-06-30 | -1.32% | -43.48% | -500% | 122/159 | 2.66% | 百利天恒 | 186.89% | 行业排名> |
| 2024-03-31 | -0.22% | -29.41% | 92.23% | 117/159 | 2.32% | 百利天恒 | 188.56% | 行业排名> |
| 2023-12-31 | -2.83% | 47.69% | -8.85% | 112/159 | -1.03% | 小方制药 | 41.8% | 行业排名> |
| 2023-09-30 | -2.6% | -48.57% | -182.61% | 123/159 | 2.34% | 拓新药业 | 20.51% | 行业排名> |
| 2023-06-30 | -0.92% | 64.34% | -441.18% | 120/159 | 1.46% | 拓新药业 | 19.87% | 行业排名> |
| 2023-03-31 | -0.17% | 86.18% | 96.86% | 120/159 | 1.37% | 拓新药业 | 19.91% | 行业排名> |
| 2022-12-31 | -5.41% | 24.76% | -209.14% | 120/159 | 0.67% | 小方制药 | 55.57% | 行业排名> |
| 2022-09-30 | -1.75% | -271.57% | 32.17% | 116/159 | 2.8% | 福元医药 | 25.41% | 行业排名> |
| 2022-06-30 | -2.58% | -56.36% | -109.76% | 125/159 | 2.16% | 小方制药 | 34.81% | 行业排名> |
| 2022-03-31 | -1.23% | -131.62% | 82.89% | 124/159 | 1.57% | 退市金泰 | 10.74% | 行业排名> |
| 2021-12-31 | -7.19% | 73.34% | -804.9% | 125/159 | 0.75% | 人福医药 | 6.82% | 行业排名> |
| 2021-09-30 | 1.02% | 2450% | 161.82% | 112/159 | 4.43% | 小方制药 | 71.99% | 行业排名> |
| 2021-06-30 | -1.65% | 2.37% | -142.42% | 121/159 | 2.94% | 汇宇制药 | 39.25% | 行业排名> |
| 2021-03-31 | 3.89% | 848.08% | 114.42% | 22/159 | 2.49% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-12-31 | -26.97% | -331.5% | -67525% | 133/159 | 3.58% | 哈三联 | 27.17% | 行业排名> |
| 2020-09-30 | 0.04% | -99.1% | 102.37% | 98/159 | 3.03% | 汇宇制药 | 55.94% | 行业排名> |
| 2020-06-30 | -1.69% | -178.6% | -225% | 111/159 | 4.19% | 河化股份 | 45.32% | 行业排名> |
| 2020-03-31 | -0.52% | -142.62% | -104.46% | 91/159 | 2.19% | 汇宇制药 | 31.9% | 行业排名> |
| 2019-12-31 | 11.65% | 373.58% | 162.98% | 46/159 | 2.53% | 誉衡药业 | 35.56% | 行业排名> |
| 2019-09-30 | 4.43% | -23.49% | 106.05% | 75/159 | 7.48% | 奥赛康 | 35% | 行业排名> |
| 2019-06-30 | 2.15% | 19.44% | 76.23% | 84/159 | 4.96% | 奥赛康 | 28.15% | 行业排名> |
| 2019-03-31 | 1.22% | -53.44% | -50.41% | 80/159 | 2.41% | 宏源药业 | 21.91% | 行业排名> |
| 2018-12-31 | 2.46% | -13.07% | -57.51% | 106/159 | 6.99% | 奥赛康 | 9.7% | 行业排名> |
| 2018-09-30 | 5.79% | 56.91% | 221.67% | 58/159 | 7.18% | 奥赛康 | 40.69% | 行业排名> |
| 2018-06-30 | 1.8% | -22.75% | -31.3% | 84/159 | 4.6% | 信立泰 | 25.93% | 行业排名> |
| 2018-03-31 | 2.62% | 95.52% | -7.42% | 39/159 | 2.54% | 昂利康 | 15.91% | 行业排名> |
| 2017-12-31 | 2.83% | 462.82% | -23.31% | 103/159 | 9.61% | 奥赛康 | 12.08% | 行业排名> |
| 2017-09-30 | 3.69% | 30.39% | 58.37% | 68/159 | 8.29% | 一品红 | 31.62% | 行业排名> |
| 2017-06-30 | 2.33% | 117.76% | 73.88% | 79/159 | 5.58% | 丽珠集团 | 49.43% | 行业排名> |
| 2017-03-31 | 1.34% | 14.53% | 271.79% | 56/159 | 2.09% | 河化股份 | 54.24% | 行业排名> |
| 2016-12-31 | -0.78% | -158.21% | -127.56% | 107/159 | 6.19% | 华东医药 | 7.2% | 行业排名> |
| 2016-09-30 | 2.83% | 177.45% | 164.49% | 68/159 | 5.61% | 南新制药 | 81.7% | 行业排名> |
| 2016-06-30 | 1.07% | 30.49% | -8.55% | 75/159 | 3.48% | 德展健康 | 29.5% | 行业排名> |
| 2016-03-31 | 1.17% | 200% | -12.69% | 55/159 | 2.65% | 贝达药业 | 16.78% | 行业排名> |
| 2015-12-31 | 1.34% | 78.67% | 31.37% | 89/159 | 11.27% | 河化股份 | 19.29% | 行业排名> |
| 2015-09-30 | 1.02% | 158.62% | 24.39% | 66/159 | 7.22% | 一品红 | 58.17% | 行业排名> |
| 2015-06-30 | 0.82% | 131.78% | 110.26% | 67/159 | 4.87% | 华东医药 | 36.97% | 行业排名> |
| 2015-03-31 | 0.39% | 120.21% | -48% | 63/159 | 2.41% | 华东医药 | 26.63% | 行业排名> |